Skip to main content

Effect of a Multidisciplinary Intervention on Fatigue in Lymphoma Survivors With Persistent Fatigue: A Randomized Controlled Trial (the REFUEL trial)

In brief

A 12-week program lowered lymphoma survivors' fatigue scores by 3.5 points

In a randomized trial of 150 lymphoma survivors with persistent fatigue, a 12-week program combining education, exercise, cognitive behavioral strategies and nutrition counseling lowered fatigue scores by 3.5 points more than usual care at 3 months. The benefit was still evident at 6 months but not 9 months, so how to sustain improvement remains unclear.

Journal
Journal of clinical oncology : official journal of the American Society of Clinical Oncology (Q1)
Published
20 November 2026
Study design
Randomized controlled trial
Evidence level
Level 1, High (CEBM 1b)
Authors
Synne-Kristin H Bøhn, Tone Skaali, Torbjørn Wisløff, Cecilie E Kiserud, Alexander Fosså, Mette Seland, et al.
PMID
43063370
DOI
10.1200/JCO-26-00414

Why clinicians should know about it

  • Picked for Hematology (top studies of the week, 22 November 2026): Randomized trial of fatigue management in lymphoma survivors

Abstract

PURPOSE: Persistent fatigue is a prevalent, complex, and distressing late effect among lymphoma survivors. We examined the effect of a multidisciplinary intervention on fatigue among lymphoma survivors with persistent fatigue. METHODS: Lymphoma survivors with persistent fatigue (moderate to severe fatigue ≥6 months) were randomly assigned to usual care (n = 75) or a 12-week multidisciplinary intervention (n = 75). The intervention consisted of patient education, physical exercise, a cognitive-behavioral therapy-based program, and nutritional counseling. Total fatigue was assessed by the Chalder Fatigue Questionnaire (range, 0-33) 3 months after random assignment (T1; primary outcome) and at 6 (T2) and 9 (T3) months after random assignment (secondary outcomes). Other secondary outcomes were functioning and global health status/quality of life (QoL) assessed by European Organisation for Research and Treatment of Cancer QoL Questionnaire-C30. Effects were analyzed with baseline-adjusted linear mixed models for repeated measures. RESULTS: Compared with usual care, the intervention group reported significantly lower total fatigue at T1 (between-group difference [BGD], -3.5 [95% CI, -5.4 to -1.6]; P < .001). Secondary outcome analyses indicated that total fatigue remained lower in the intervention group at T2 (BGD, -2.4 [95% CI, -4.4 to -0.5]), but not at T3 (BGD, -0.9 [95% CI, -3.0 to 1.2]). At T1, secondary outcome analyses indicated positive intervention effects on physical (BGD, 3.8 [95% CI, 0.2 to 7.3]) and role functioning (BGD, 9.2 [95% CI, 0.9 to 17.5]) and global health status/QoL (BGD, 9.5 [95% CI, 3.5 to 15.4]), but not on social (BGD, -0.1 [95% CI, -7.4 to 7.3]), emotional (BGD, 5.6 [95% CI, 0.0 to 11.3]), or cognitive functioning (BGD, 3.5 [95% CI, -3.3 to 10.2]). CONCLUSION: A multidisciplinary intervention improved fatigue among lymphoma survivors with persistent fatigue. The effect appeared to be maintained 6 months after random assignment but dissipated at 9 months.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.